NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $313,952 | +5.3% | 3,082 | +4.3% | 0.26% | +5.8% |
| Q2 2023 | $298,107 | +12.3% | 2,954 | +2.4% | 0.24% | +4.3% |
| Q1 2023 | $265,530 | +7.9% | 2,886 | +6.4% | 0.23% | -3.3% |
| Q4 2022 | $246,123 | +20.1% | 2,713 | +0.4% | 0.24% | +10.6% |
| Q3 2022 | $205,000 | -10.5% | 2,702 | -0.4% | 0.22% | -3.6% |
| Q2 2022 | $229,000 | -4.6% | 2,712 | -0.7% | 0.22% | +16.0% |
| Q1 2022 | $240,000 | +2.1% | 2,732 | +1.8% | 0.19% | +6.6% |
| Q4 2021 | $235,000 | +11.9% | 2,683 | +4.6% | 0.18% | +2.8% |
| Q3 2021 | $210,000 | -10.3% | 2,565 | +0.2% | 0.18% | -8.8% |
| Q2 2021 | $234,000 | +8.3% | 2,560 | +1.3% | 0.19% | +0.5% |
| Q1 2021 | $216,000 | -11.8% | 2,526 | -3.7% | 0.19% | -17.2% |
| Q4 2020 | $245,000 | – | 2,622 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |